Pfizer Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/2/2026)
| Balance Sheet | Total Assets | 208,160,000,000.00 | ROE | 41.54 % |
| Balance Sheet | Total Equity | 86,476,000,000.00 | ROA | 3.73 % |
| Cashflow | Capital Expenditures | -2,629,000,000.00 | P/FCF | 18.30 |
| Cashflow | Free Cash Flow | 9,075,000,320.00 | – | – |
| Cashflow | Operating Cash Flow | 11,704,000,000.00 | P/CF | 14.19 |
| Income | Earnings per Share (diluted) | 1.36 | Div. Yield | 5.89 % |
| Income | Net Income | 7,770,000,000.00 | P/E | 21.48 |
| Income | Shares Outstanding | 5,686,000,000.00 | P/B | 1.92 |
| Income | Total Revenue | 62,579,000,000.00 | P/S | 2.65 |
Ratios calculated on: 10/14/2026
Company Description
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Primary Care operating segment includes revenues from human prescription pharmaceutical products primarily prescribed by primary-care physicians. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc. On November 30, 2012, the Company completed the sale of its Nutrition business.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.pfizer.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more